Abstract
When proceeding with hormone therapy or gender affirming surgery, transgender patients should have the option of undergoing fertility preservation [1]. Prior to assisted reproductive technology, transgender men have traditionally had to discontinue exogenous testosterone for up to 6 months or until resumption of menses [2]. The process and experience associated with stopping testosterone has proven to be distressing for patients [3]. This report explores the feasibility of proceeding with fertility preservation in a transgender man without an extended period of androgen cessation and without the resumption of menstruation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
